成人B站猎奇版

News, features, and commentary about cancer-related issues

Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says

Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion

News, features, and commentary about cancer-related issues

Regimen tops best historical response rate with chemoimmunotherapy in this setting

News, features, and commentary about cancer-related issues

Incidence almost identical to that with standard cancer treatment in randomized trials

For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline

Patient achieves remission with biologic agent currently used for myeloma

Having a medical condition was tied to increased risk of suicide in a dose-response-like manner

Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%

Responses to pirtobrutinib observed in patients with previously treated disease

Results from some pulmonary function tests even showed improvement 3 years post-transplant

Better survival in one registry study, detriment with class I HLA mismatch in another